Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06036056Recruiting
Blood Chemistry Study in Mild ARDS
This study uses a special blood test (called NMR metabolomics) to understand how your body's chemistry changes in the early stages of mild ARDS. It may help find better ways to treat this serious lung condition.
Lucknow, Uttar PradeshAges 18–65 - NCT06036810Recruiting
Spanish decision tool for ovarian cancer maintenance
This study tests a Spanish-language decision tool to help people with advanced ovarian cancer choose the best maintenance therapy after chemotherapy. It is for patients who can read or speak Spanish and are eligible for maintenance treatment.
Houston, TexasAges 18 years+ - NCT06037902Recruiting
CPAP during radiation for esophageal cancer
This study tests whether using a CPAP mask (which gently pushes air into your airways) during radiation therapy makes treatment safer and more effective for esophageal cancer. It is for adults who are planning radiation and can tolerate wearing the mask.
Ramat GanAges 18 years+ - NCT06039696Recruiting
Testing a new way to find infections in liver disease patients
This trial uses a DNA test to better detect infections in people with advanced liver disease who are hospitalized. It may help doctors find the right treatment faster.
Guangzhou, GuangdongAges 18–80 - NCT06040827Recruiting
Study of a knee implant extension for knee replacement
This trial is for adults having their first knee replacement surgery. It tests a special part (tibial extension) of a common knee implant system. Researchers will follow participants over time to see how well it works.
Fayetteville, ArkansasAges 18 years+ - NCT06041997Recruiting
Limiting smartphone use for headache relief
This trial tests whether reducing smartphone use can help treat primary headaches (migraines or tension headaches) in adults. If you get headaches that aren't caused by another medical condition, this study might be a good fit.
New Delhi, National Capital Territory of DelhiAges 18 years+ - NCT06043362Recruiting
Nicotine pouches for daily smokers
This study tests if nicotine pouches can help daily smokers reduce how many cigarettes they smoke. You'll try nicotine pouches, and researchers will track your progress.
Hershey, PennsylvaniaAges 21–70 - NCT06043843Recruiting
Video Education to Reduce Diabetes Risks During Ramadan
This study tests whether focused video education can help people with type 2 diabetes manage their blood sugar safely while fasting during Ramadan. You will receive extra teaching and support through video calls to reduce the risk of complications.
SingaporeAges 21–100 - NCT06045338Recruiting
Mind-body program for long COVID symptoms
This trial tests a mind-body intervention to help people with ongoing long COVID symptoms like pain, fatigue, or brain fog. If you've had COVID-19 and have had symptoms at least 3 days a week for 3 months, this study might help.
Boston, MassachusettsAges 18–65 - NCT06047028Recruiting
Heart MRI scan to assess tissue health
This study uses a special MRI scan to look at heart muscle metabolism in people with heart failure caused by blocked arteries. It may help doctors better understand which heart tissue is still alive and could recover.
Dallas, TexasAges 20–80 - NCT06047236Recruiting
Immune markers in salivary gland cancer
This study looks at immune cells and substances in blood, saliva, and stool from people with salivary gland cancer. The goal is to find markers that could help predict how the disease behaves.
Erlangen, BavariaAges 18 years+ - NCT06048159Recruiting
Brain stimulation to improve memory after stroke-related aphasia
This study tests a safe, non-invasive brain stimulation called tACS to see if it can help improve short-term memory for sounds and words in people who have trouble speaking after a stroke. If you have aphasia from a left-brain stroke, this treatment might help your brain relearn how to remember and repeat what you hear.
Milwaukee, WisconsinAges 18 years+ - NCT06048250RecruitingPhase 1
Mezigdomide after Abecma for multiple myeloma
This trial tests a new drug called mezigdomide (CC-92480) for people with multiple myeloma who have already received the CAR T-cell therapy Abecma. The goal is to see if mezigdomide can help keep the cancer under control after Abecma.
Duarte, CaliforniaAges 18 years+ - NCT06050200Recruiting
Growth Observation in Liver Surgery
This trial studies a way to help people who need liver surgery but have a very small remaining liver after the operation. It tests a special growth observation approach to see if it can safely increase the size of the future liver remnant.
Warsaw, Masovian VoivodeshipAges 18–80 - NCT06050733Recruiting
Gut bacteria and immunotherapy response in solid tumors
This study looks at how the bacteria in your gut may affect how well immunotherapy works for solid cancers that have spread or cannot be removed. It focuses on people who have been on certain immunotherapy drugs (PD-1 or PD-L1 inhibitors) for at least 3 months but less than 2 years.
Galveston, TexasAges 35–75 - NCT06051201Recruiting
ReceptIVFity test for IVF success prediction
This trial studies a vaginal swab test called ReceptIVFity that looks at the bacteria in your vagina to see if it can help predict how well IVF will work. You can join if you're about to start your first IVF cycle, are not on hormonal birth control or antibiotics, and your IVF is not for emergency reasons.
RotterdamAges 18–42 - NCT06051227RecruitingPhase 3
Pain relief after injury: fentanyl vs. esketamine
This trial compares two strong pain medicines—fentanyl and esketamine—to see which works better for treating pain right after a traumatic injury. You would receive the medicine by spray in your nose or through a vein before going to the hospital.
AmsterdamAges 18 years+ - NCT06051253RecruitingPhase 4
Personalized infliximab dosing for active Crohn's fistulas
This study tests whether adjusting the dose of infliximab (a biologic medicine given by IV) based on drug levels in your blood works better for treating draining fistulas caused by Crohn's disease. It is for people who have not tried other biologics and whose fistulas have not healed with usual treatments.
SeoulAges 19–80 - NCT06051760RecruitingPhase 1
NV-001 for advanced solid tumors after standard treatments
This trial tests a new drug called NV-001 for people with advanced solid tumors that are no longer responding to standard treatments. It aims to see if the drug is safe and can help shrink or slow tumor growth.
Beijing, Beijing MunicipalityAges 18–75 - NCT06052033Recruiting
Light therapy vs. laser for persistent cervical changes with HPV
This study compares two treatments—photodynamic therapy using a special light-activated cream and a CO2 laser—to see which works better for clearing low-grade cervical changes caused by a long-lasting high-risk HPV infection. The goal is to find a safe, effective option for women who have had this condition for over a year.
Wenzhou, ZhejiangAges 18–65 - NCT06052098Recruiting
Comparing two ablation methods for early-stage lung cancer
This study compares two ways to destroy early-stage lung cancer without surgery: one using a needle through the chest (CT-guided) and another using a thin tube through the mouth (bronchoscopy-guided). It might be an option if you have small, outer-edge lung cancer and cannot or prefer not to have surgery.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06052826RecruitingPhase 2
Geriatric support to speed recovery after CAR-T for older adults
This study tests whether extra geriatric support before and after CAR-T cell therapy helps people 60 and older recover faster. It is for patients with B-cell non-Hodgkin lymphoma or multiple myeloma who are scheduled for an FDA-approved CAR-T treatment.
Duarte, CaliforniaAges 60 years+ - NCT06053476Recruiting
Chest tube and pain care after lung surgery for collapsed lung
This study compares two ways to manage the chest tube and pain after surgery for a collapsed lung (pneumothorax). The goal is to find out which approach helps patients recover faster and with less pain.
VeldhovenAges 16 years+ - NCT06053554Recruiting
Comparing two cataract surgery methods for pseudoexfoliation
This study compares two different surgical methods for placing a new artificial lens (IOL) during cataract surgery in people with pseudoexfoliation syndrome. It aims to find which method works best for these patients.
ViennaAges 60–100
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.